sb 203580 has been researched along with kallidin in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (kallidin) | Trials (kallidin) | Recent Studies (post-2010) (kallidin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 534 | 12 | 24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, A; Fox, A; Ganju, P; Núñez, X; Patel, S | 1 |
| Brunius, G; Domeij, H; Gustavsson, A; Yucel-Lindberg, T | 1 |
2 other study(ies) available for sb 203580 and kallidin
| Article | Year |
|---|---|
p38 stress-activated protein kinase inhibitor reverses bradykinin B(1) receptor-mediated component of inflammatory hyperalgesia.
Topics: Animals; Cell Line; Cyclooxygenase 2; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hindlimb; Humans; Hyperalgesia; Imidazoles; Inflammation; Interleukin-1; Isoenzymes; Kallidin; Male; Membrane Proteins; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B1; Receptors, Bradykinin; Tumor Necrosis Factor-alpha | 2001 |
Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha.
Topics: Adolescent; Bradykinin; Bradykinin B2 Receptor Antagonists; Calcimycin; Cells, Cultured; Child; Fibroblasts; Gingiva; Humans; Imidazoles; Indoles; Interleukin-1; Interleukin-8; Ionophores; Kallidin; Maleimides; MAP Kinase Kinase 2; Protein Kinase C; Pyridines; Receptor, Bradykinin B2; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |